Therefore, pending further clinical research studies that sheds light into these structural aberrations and derailment of drainage pathways, deciphering the fluctuations of GFAP in AD and TBI needs to be taken into cognizance with careful forethought. This evidence concerns the gene GFAP and Alzheimer disease.